ECOG-ACRIN ENDURANCE Trial Publishes Randomized Evidence on Lenalidomide Maintenance Duration in Multiple Myeloma
A landmark phase 3 trial in newly diagnosed multiple myeloma challenges a long-standing standard: indefinite lenalidomide maintenance. For patients who ...
